Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

650
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
650

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunosuppression after pediatric liver transplantation may lead to early and prolonged acute thymic involution: findings from a pilot longitudinal study.

Frontiers in immunology·2026
Same author

Extracellular matrix mediated neuroendocrine control of the thymus.

Neuroimmunomodulation·2026
Same author

Digitalisation, human factors, and mental health among primary care professionals aged ≥ 50 years: a mixed-methods case study in Portugal.

BMC health services research·2026
Same author

High-throughput time-lapse imaging of B16 target cell killing by ovalbumin-specific CD8<sup>+</sup> T cells.

Methods in cell biology·2026
Same author

AID and TET2 cooperate to demethylate Irf4 for plasma cell fate in germinal center B cells.

The Journal of experimental medicine·2026
Same author

Zika virus infection disturbs development of human muscle progenitor cells.

Frontiers in cellular and infection microbiology·2026

Related Experiment Video

Updated: Sep 2, 2025

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.4K

Integrin-directed antibody-based immunotherapy: focus on VLA-4.

Wilson Savino1,2,3, Beatriz Chaves1,2,4, Adriana Cesar Bonomo1,2,3

  • 1Laboratory on Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.

Immunotherapy Advances
|August 3, 2022
PubMed
Summary

Targeting the VLA-4 integrin pathway shows promise for treating inflammatory diseases by blocking T cell migration. However, risks associated with current therapies necessitate developing safer, next-generation antibody reagents.

Keywords:
T cellscell traffickingimmunotherapyneuroimmunology

More Related Videos

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of &#946;2 Integrin Activation
04:15

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation

Published on: February 2, 2024

1.9K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

Related Experiment Videos

Last Updated: Sep 2, 2025

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.4K
Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of &#946;2 Integrin Activation
04:15

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation

Published on: February 2, 2024

1.9K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Medicine

Background:

  • Chronic inflammatory diseases involve leukocyte infiltration, with T lymphocytes playing a key role.
  • Integrins, such as VLA-4, mediate leukocyte adhesion and transmigration across endothelial barriers.
  • Blocking VLA-4 interactions has therapeutic potential in autoimmune and inflammatory conditions.

Purpose of the Study:

  • To review the role of VLA-4 integrin in leukocyte migration in inflammatory diseases.
  • To discuss the therapeutic applications and limitations of anti-VLA-4 antibodies.
  • To highlight the need for developing novel antibody reagents.

Main Methods:

  • Literature review of studies on integrin function in leukocyte trafficking.
  • Analysis of clinical data regarding the efficacy and safety of anti-VLA-4 therapies.
  • Discussion of molecular mechanisms underlying VLA-4 mediated cell migration.

Main Results:

  • VLA-4 is crucial for T cell migration into inflamed tissues and across endothelial barriers.
  • Anti-VLA-4 monoclonal antibodies (e.g., Natalizumab) are effective in multiple sclerosis and inflammatory bowel disease.
  • Natalizumab use is associated with progressive multifocal leukoencephalopathy, limiting its application.

Conclusions:

  • Targeting VLA-4 is a validated strategy for managing inflammatory diseases.
  • The risk of serious side effects necessitates the development of improved therapeutic agents.
  • Next-generation, smaller, and more specific antibody reagents are a promising future direction.